Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids

Clin Pharmacol Ther. 1982 Nov;32(5):566-71. doi: 10.1038/clpt.1982.204.

Abstract

To investigate the effect of glucocorticoids on beta-agonist-induced desensitization, we studied the effect of a single intravenous dose of methylprednisolone (2 mg/kg) on beta-receptor density and affinity in lymphocytes from four normal and four mildly asthmatic subjects at the end of 3 to 5 wk of terbutaline therapy and from four normal subjects taking no other drug. Terbutaline decreased (-)[3H]-dihydroalprenolol binding sites by 53% in normal and by 42% in asthmatic subjects. Methylprednisolone restored the number of binding sites to levels statistically indistinguishable from the preterbutaline values in both groups of subjects. In subjects not exposed to terbutaline beforehand there was no significant alteration in receptor density after methylprednisolone, nor in normal lymphocytes incubated in vitro for 90 min with hydrocortisone (10(-5)M). No significant change in the dissociation constant was observed in any situation. A single intravenous dose of methylprednisolone reverses terbutaline-induced down-regulation of beta-adrenoceptors. This may provide a mechanism for the beneficial effect of steroids in restoring catecholamine responsiveness in asthmatic subjects.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Asthma / metabolism
  • Humans
  • Lymphocytes / drug effects
  • Methylprednisolone / pharmacology*
  • Receptors, Adrenergic / drug effects*
  • Receptors, Adrenergic, beta / drug effects*
  • Terbutaline / metabolism

Substances

  • Receptors, Adrenergic
  • Receptors, Adrenergic, beta
  • Terbutaline
  • Methylprednisolone